Trials / Unknown
UnknownNCT05521035
Risk and Incidence of Aortic Graft and Endograft Infection With BSI
Risk and Incidence of Aortic Graft and Endograft Infection in Patients With Bloodstream Infection, a Population Based Study in South Sweden
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Lund University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
What is the risk of aortic vascular graft and endograft infection in patients with aortic vascular graft/endograft and bloodstream infection?
Detailed description
All patients with previous aortic vascular graft and endograft surgery between years 2010 and 2021 in four regions of south Sweden (Skåne, Halland, Kronoberg and Blekinge) will be included in the study. These patients will be evaluated for bloodstream infection (BSI) or not. For all patients with BSI, the risk of aortic vascular graft and endograft infection will be investigated. Aortic vascular graft and endograft infection will be determined by usage of the MAGIC-criteria. Risk factors for developing aortic vascular graft and endograft infection will be investigated, and if possible used to construct a risk score. This risk score could be used by clinicians to determine if bacteremic patients with aortic vascular grafts or endografts should be evaluated for aortic vascular graft and endograft infection.
Conditions
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2022-08-30
- Last updated
- 2023-12-14
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05521035. Inclusion in this directory is not an endorsement.